Trials / Completed
CompletedNCT01035515
BIIB014 Cardiovascular Monitoring Study
A Single-Center, Randomized, Placebo-Controlled, Double-Blind, Crossover Study to Evaluate the Cardiovascular Effects of Single Doses of Oral BIIB014 in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Biogen · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The study will examine the effects of a single dose of BIIB014 on blood pressure and haemodynamic variables in healthy volunteers over 24 hours.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Single dose oral capsule placebo comparator |
| DRUG | BIIB014 50mg | Single dose oral capsule 50mg BIIB014 |
| DRUG | BIIB014 100mg | Single dose oral capsule 100mg BIIB014 |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2010-04-01
- Completion
- 2010-04-01
- First posted
- 2009-12-18
- Last updated
- 2010-06-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01035515. Inclusion in this directory is not an endorsement.